查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2158671

皮膚抗真菌藥物市場：全球市場預測，2026-2032年

Antifungal Drugs for Skin Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，皮膚抗真菌藥物市場規模將成長至 88.8 億美元，年複合成長率為 6.85%。

主要市場統計數據
基準年 2025 55.8億美元
預計年份：2026年 59.9億美元
預測年份 2032 88.8億美元
複合年成長率 (%) 6.85%

皮膚抗真菌藥物：執行摘要

皮膚抗真菌藥物用於治療發生在皮膚、足部、鼠蹊部、指甲及相關部位的表淺真菌感染疾病。治療方案包括外用乳膏、軟膏、粉末、噴霧劑、溶液和洗髮劑，以及針對特定感染疾病和廣泛感染疾病的口服藥物。臨床決策取決於疑似病原體、感染部位、嚴重程度、復發情況、患者年齡、共病、藥物交互作用的風險。

治療方式正朝著更有針對性和更便捷的照護方向發展。

治療方法正在重組，重點在於準確診斷、縮短治療時間、簡化治療流程以及遵守用藥。局部用藥對於局部疾病仍然至關重要，而口服治療通常僅限於局部治療效果不佳或不適用的情況。聯合治療、更清晰的患者指導、改進的包裝以及藥劑師的參與有助於解決治療不徹底和症狀復發的問題。此外，推廣合理使用抗生素的措施正在促使人們更有選擇性地使用全身性治療，並更加重視區分真菌感染疾病與皮膚炎、細菌性疾病和其他類似疾病。

人工智慧 (AI) 在診斷、藥物依從性和發育支援方面的應用

人工智慧可以透過影像輔助評估、臨床決策支援、治療反應監測和患者自述症狀分析等方式為該領域做出貢獻。雖然這些工具可以幫助識別需要確診檢測或專家會診的病例，但它們並不能取代臨床檢測，必要時仍需進行顯微鏡檢查、培養或其他診斷方法。在研發領域，人工智慧可以輔助化合物篩檢、製劑最佳化、安全訊號檢測和臨床試驗參與者招募。實施的優先順序應包括：使用經過驗證的資料集、檢驗透明的性能指標、保護隱私以及採取安全措施，以防止不恰當的自我診斷和不必要的抗真菌藥物使用。

區域趨勢反映了交通便利性、氣候和醫療保健途徑。

在北美，非處方外用藥物的廣泛普及與完善的皮膚科和基層醫療服務相結合。而在歐洲，循證處方、藥局的便利性和市場監管的一致性則備受重視。亞太地區的醫療保健體系和氣候條件各不相同，潮濕的環境和診斷資源的匱乏會影響治療需求。在拉丁美洲，藥物可近性、基層醫療體系和經濟負擔等因素都會影響治療效果。在中東，氣候、人口流動性和醫療保健系統的組織差異會影響診斷和治療的連續性。在非洲，由於診斷資源、藥物供應和醫療基礎設施有顯著差異，實用的劑型、訓練有素的第一線醫護人員和可靠的藥品供應系統尤其重要。

東協、金磚國家、歐盟、七國集團、海灣合作理事會和北約各自的優先事項各不相同。

東協成員國共用的區域性挑戰，例如熱帶或潮濕環境、監管體系的多樣性以及皮膚科醫療服務取得方面的差異。金磚國家則擁有龐大且多元化的人口，其製造業、分銷和基層醫療能力各不相同。歐盟雖然在監管協調方面具有優勢，但仍需解決各國在報銷制度和醫療服務結構上的差異。七國集團（G7）國家通常擁有更完善的診斷基礎設施和成熟的合理用藥框架，但醫療服務的可近性、用藥依從性和老年照護需求仍然是重大挑戰。海灣合作理事會（GCC）國家的醫療衛生系統通常將先進的都市區醫療服務與高流動性和易受氣候因素影響的人口結構相結合，因此，醫療服務的連續性至關重要。北約成員國的醫療衛生體系各不相同，因此，與其採用單一的治療模式，不如從通用的韌性、採購和準備工作等方面來理解它們更為恰當。

每個國家的優先事項包括獲得醫療保健和診斷服務以及藥物管理。

在澳大利亞，由於人口地域分散，藥房、遠端醫療和藥品供應的連續性至關重要。巴西和墨西哥需要採取措施解決醫療保健和藥品分銷的區域差異。加拿大和美國在強大的臨床能力、可負擔性、適當的自我護理以及合理使用抗生素方面都取得了成功。中國和印度擁有龐大且多元化的醫療保健網路，都市區地區在產品品質、診斷和醫療服務可近性方面存在差異。法國、德國、義大利、西班牙和英國繼續致力於提高患者的用藥依從性和確保治療階段的合理過渡，同時強調實證醫學、藥物監管以及初級和專科醫療之間的協調。日本和韓國擁有先進的醫療保健基礎設施和老齡化人口，因此對便捷且微創的治療方式的需求日益成長。俄羅斯的市場環境受到醫療保健可近性、藥品分銷可靠性和臨床服務方面區域差異的影響。

行業領導者應優先考慮診斷、用藥依從性和負責任的獲取途徑。

產業領導者應加強產品在不同感染部位和病患小組的療效證據，支持清晰的標籤，並設計符合臨床常規的劑型。投資於診斷教育、藥劑師和基層醫療醫生的培訓以及轉診途徑，可以減少對非真菌性疾病的不當治療。在專家指導下使用數位化用藥依從性支援工具和經過嚴格檢驗的影像輔助技術，可以提高治療依從性。供應計劃應考慮區域性獲取差異，而藥物管理計劃應限制不必要的全身性治療。與醫療保健提供者和公共衛生機構的合作有助於在不鼓勵濫用藥物的情況下，並擴大合理用藥範圍。

調查方法執行摘要

本概要基於所提供的市場範圍（皮膚抗真菌藥物）對各項評估進行了整理，涵蓋治療趨勢、人工智慧 (AI) 應用、地區、國家/地區組以及特定國家/地區。評估結果是基於既定的臨床和醫療機構考慮因素，例如劑型、診斷實踐、用藥依從性、可近性、藥物管理、法規和分銷。本分析有意排除市場規模估計、市場佔有率、預測、公司間比較。針對不同地區和國家的說明反映的是氣候、醫療系統能力、法規、經濟負擔能力以及醫療服務結構的差異，而非數值排名。

市場的策略重點不僅是增加治療次數，而是提供更好的照護。

皮膚抗真菌藥物領域正朝著更精準的診斷、更方便的治療、更合理的用藥途徑和更完善的連續性照護方向發展。由於地區和國家之間的差異，成功的策略必須根據當地的醫療保健系統、氣候、藥品分銷和患者行為進行調整。雖然人工智慧在有效性得到檢驗並進行臨床管理後可以發揮價值，但最根本的優先事項仍然是可靠的藥物、合理的處方、患者教育以及對持續性或嚴重的及時專家評估。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：皮膚用抗真菌藥物市場：依藥物類別分類

  • Allylamines基
  • 唑類
    • 咪唑衍生物
    • 三唑
  • Polyenes

第8章：皮膚用抗真菌藥物：依劑型分類

  • 奶油
  • 凝膠
  • 軟膏
  • 粉末
  • 噴

第9章：皮膚用抗真菌藥物市場：依產品類型分類

  • 非處方藥
  • 處方

第10章：皮膚用抗真菌藥物市場：依分銷管道分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第11章：皮膚抗真菌藥物：按適應症

  • 體癬
  • 股癬
  • 香港腳

第12章：皮膚用抗真菌藥物：依給藥途徑

  • 口服
  • 外用

第13章：皮膚抗真菌藥物：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：皮膚用抗真菌藥物市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：皮膚用抗真菌藥物市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Astellas Pharma Inc
  • Bausch Health Companies Inc
  • Bayer AG
  • Cipla Ltd
  • Dr. Reddy's Laboratories Ltd
  • GlaxoSmithKline plc
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
  • Sandoz International GmbH
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc

第18章 主要專家

Product Code: MRR-4654A89DBB78

The Antifungal Drugs for Skin Market is projected to grow by USD 8.88 billion at a CAGR of 6.85% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.58 billion
Estimated Year [2026] USD 5.99 billion
Forecast Year [2032] USD 8.88 billion
CAGR (%) 6.85%

Antifungal Drugs for Skin: Executive Summary

Antifungal drugs for skin are used to treat superficial fungal infections affecting the skin, feet, groin, nails, and related areas. The therapeutic landscape includes topical creams, ointments, powders, sprays, solutions, and shampoos, alongside oral medicines for selected or extensive infections. Clinical decision-making depends on the suspected organism, infection site, severity, recurrence, patient age, comorbidities, and risk of drug interactions.

Treatment Is Shifting Toward Targeted, Convenient Care

The landscape is being reshaped by stronger emphasis on accurate diagnosis, shorter and simpler treatment routines, and improved adherence. Topical formulations remain important for localized disease, while oral therapy is generally reserved for circumstances in which topical treatment is inadequate or inappropriate. Combination approaches, clearer patient instructions, improved packaging, and pharmacist involvement can help address incomplete courses and recurrent symptoms. Antimicrobial stewardship is also encouraging more selective use of systemic therapy and greater attention to distinguishing fungal infection from dermatitis, bacterial disease, and other look-alike conditions.

Artificial Intelligence Supports Diagnosis, Adherence, and Development

Artificial intelligence can contribute to this field through image-assisted assessment, clinical decision support, treatment-response monitoring, and analysis of patient-reported symptoms. These tools may help identify cases that warrant confirmatory testing or professional review, but they do not eliminate the need for clinical examination and, where appropriate, microscopy, culture, or other diagnostic methods. In research and development, artificial intelligence can support compound screening, formulation optimization, safety-signal detection, and trial recruitment. Implementation should prioritize validated datasets, transparent performance measures, privacy protection, and safeguards against inappropriate self-diagnosis or unnecessary antifungal use.

Regional Dynamics Reflect Access, Climate, and Care Pathways

North America combines broad access to over-the-counter topical products with established dermatology and primary-care services, while Europe places strong emphasis on evidence-based prescribing, pharmacy access, and regulatory consistency across markets. Asia-Pacific includes diverse healthcare systems and climates, with humid conditions and uneven access to diagnosis influencing treatment needs. Latin America is shaped by variable availability of medicines, primary-care capacity, and affordability considerations. In the Middle East, climate, population mobility, and differences in health-system organization affect diagnosis and treatment continuity. Africa faces substantial variation in diagnostic access, medicine availability, and healthcare infrastructure, making practical formulations, trained frontline providers, and reliable supply particularly important.

ASEAN, BRICS, EU, G7, GCC, and NATO Show Distinct Priorities

ASEAN members share regional concerns related to tropical or humid environments, varied regulatory systems, and uneven access to dermatology services, while BRICS countries span large and diverse populations with differing manufacturing, distribution, and primary-care capabilities. The European Union benefits from regulatory coordination but still must address differences in national reimbursement and healthcare delivery. G7 countries generally have stronger diagnostic infrastructure and established stewardship frameworks, although access, adherence, and aging-related care needs remain relevant. GCC health systems commonly combine advanced urban services with high mobility and climatic exposure, making continuity of care important. NATO members encompass varied health systems, so the group is better understood through shared resilience, procurement, and preparedness considerations than through a single treatment model.

Country Priorities Range from Access and Diagnosis to Stewardship

Australia's geographically dispersed population makes pharmacy access, telehealth, and supply continuity valuable. Brazil and Mexico require approaches that account for regional disparities in healthcare access and medicine distribution. Canada and the United States combine strong clinical capabilities with attention to affordability, appropriate self-care, and antimicrobial stewardship. China and India have large, diverse care networks in which product quality, diagnosis, and access differ across urban and rural settings. France, Germany, Italy, Spain, and the United Kingdom emphasize evidence-based treatment, regulated medicines, and coordinated primary and specialist care, while continuing to address adherence and appropriate escalation. Japan and South Korea have advanced healthcare infrastructures and aging populations, supporting demand for convenient, well-tolerated treatments. Russia's market environment is influenced by healthcare access, distribution reliability, and regional variation in clinical services.

Industry Leaders Should Prioritize Diagnosis, Adherence, and Responsible Access

Leaders should strengthen evidence for product effectiveness across infection sites and patient groups, support clear labeling, and design formulations that fit real-world routines. Investment in diagnostic education, pharmacist and primary-care training, and referral pathways can reduce inappropriate treatment of nonfungal conditions. Digital adherence tools and carefully validated image-assistance technologies may improve follow-through when used with professional oversight. Supply planning should account for regional access gaps, while stewardship programs should discourage unnecessary systemic treatment. Partnerships with healthcare providers and public-health organizations can help expand responsible access without encouraging indiscriminate self-medication.

Research Methodology for the Executive Summary

This summary uses the supplied market scope-antifungal drugs for skin-and organizes the assessment across treatment trends, artificial-intelligence applications, regions, country groups, and specified countries. Findings are framed from established clinical and healthcare-system considerations, including formulation type, diagnostic practice, adherence, access, stewardship, regulation, and distribution. The analysis deliberately excludes market estimates, market sizing, market shares, forecasts, and company-specific comparisons. Regional and group narratives reflect structural differences in climate, health-system capacity, regulation, affordability, and care delivery rather than numerical rankings.

The Market's Strategic Focus Is Better Care, Not Simply More Treatment

The antifungal-drug landscape for skin is moving toward more accurate diagnosis, convenient treatment, responsible access, and stronger continuity of care. Regional and country differences mean that successful strategies must be adapted to local health systems, climate, distribution, and patient behavior. Artificial intelligence can add value when validated and clinically governed, but fundamental priorities remain dependable medicines, appropriate prescribing, patient education, and timely professional review for persistent or severe disease.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Antifungal Drugs for Skin Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Allylamines
  • 7.3. Azoles
    • 7.3.1. Imidazoles
    • 7.3.2. Triazoles
  • 7.4. Polyenes

8. Antifungal Drugs for Skin Market, by Dosage Form

  • 8.1. Introduction
  • 8.2. Cream
  • 8.3. Gel
  • 8.4. Ointment
  • 8.5. Powder
  • 8.6. Spray

9. Antifungal Drugs for Skin Market, by Product Type

  • 9.1. Introduction
  • 9.2. Over The Counter
  • 9.3. Prescription

10. Antifungal Drugs for Skin Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacy
  • 10.3. Online Pharmacy
  • 10.4. Retail Pharmacy

11. Antifungal Drugs for Skin Market, by Indication

  • 11.1. Introduction
  • 11.2. Tinea Corporis
  • 11.3. Tinea Cruris
  • 11.4. Tinea Pedis

12. Antifungal Drugs for Skin Market, by Route Of Administration

  • 12.1. Introduction
  • 12.2. Oral
  • 12.3. Topical

13. Antifungal Drugs for Skin Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Antifungal Drugs for Skin Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Antifungal Drugs for Skin Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Astellas Pharma Inc
  • 17.3. Bausch Health Companies Inc
  • 17.4. Bayer AG
  • 17.5. Cipla Ltd
  • 17.6. Dr. Reddy's Laboratories Ltd
  • 17.7. GlaxoSmithKline plc
  • 17.8. Merck & Co Inc
  • 17.9. Novartis AG
  • 17.10. Pfizer Inc
  • 17.11. Sandoz International GmbH
  • 17.12. Sanofi S.A.
  • 17.13. Sun Pharmaceutical Industries Ltd
  • 17.14. Teva Pharmaceutical Industries Ltd
  • 17.15. Viatris Inc

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Antifungal Drugs for Skin Market, Years Considered for the Study
  • FIGURE 2. Global Antifungal Drugs for Skin Market, Research Design
  • FIGURE 3. Global Antifungal Drugs for Skin Market, Research Framework
  • FIGURE 4. Global Antifungal Drugs for Skin Market, Data Triangulation
  • FIGURE 5. Global Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Antifungal Drugs for Skin Market Size, by Drug Class, 2025 vs 2032 (%)
  • FIGURE 7. Global Antifungal Drugs for Skin Market Size, by Drug Class, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Antifungal Drugs for Skin Market Size, by Dosage Form, 2025 vs 2032 (%)
  • FIGURE 9. Global Antifungal Drugs for Skin Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Antifungal Drugs for Skin Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 11. Global Antifungal Drugs for Skin Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Antifungal Drugs for Skin Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 13. Global Antifungal Drugs for Skin Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Antifungal Drugs for Skin Market Size, by Indication, 2025 vs 2032 (%)
  • FIGURE 15. Global Antifungal Drugs for Skin Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Antifungal Drugs for Skin Market Size, by Route Of Administration, 2025 vs 2032 (%)
  • FIGURE 17. Global Antifungal Drugs for Skin Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Antifungal Drugs for Skin Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Antifungal Drugs for Skin Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Antifungal Drugs for Skin Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Antifungal Drugs for Skin Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Antifungal Drugs for Skin Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Antifungal Drugs for Skin Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Antifungal Drugs for Skin Market Segmentation & Coverage
  • TABLE 2. Global Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 4. Global Allylamines Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Allylamines Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Allylamines Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Azoles Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Azoles Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Azoles Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Imidazoles Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Imidazoles Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Imidazoles Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Triazoles Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Triazoles Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Triazoles Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Polyenes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Polyenes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Polyenes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 20. Global Cream Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Cream Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Cream Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Gel Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Gel Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Gel Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Ointment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Ointment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Ointment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Powder Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Powder Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Powder Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Spray Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Spray Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Spray Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 36. Global Over The Counter Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Over The Counter Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Over The Counter Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Prescription Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Prescription Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Prescription Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 43. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 53. Global Tinea Corporis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Tinea Corporis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Tinea Corporis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Tinea Cruris Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Tinea Cruris Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Tinea Cruris Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Tinea Pedis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Tinea Pedis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Tinea Pedis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 63. Global Oral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Oral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Oral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Topical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Topical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Topical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Asia-Pacific Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Asia-Pacific Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 72. Asia-Pacific Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 73. Asia-Pacific Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 74. Asia-Pacific Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 75. Asia-Pacific Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 76. Asia-Pacific Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 77. Asia-Pacific Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 78. North America Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. North America Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 80. North America Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 81. North America Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 82. North America Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 83. North America Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 84. North America Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 85. North America Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 86. Latin America Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Latin America Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 88. Latin America Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 89. Latin America Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 90. Latin America Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 91. Latin America Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 92. Latin America Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 93. Latin America Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 94. Europe Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 95. Europe Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 96. Europe Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 97. Europe Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 98. Europe Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 99. Europe Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 100. Europe Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 101. Europe Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 102. Middle East Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Middle East Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 104. Middle East Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 105. Middle East Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 106. Middle East Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 107. Middle East Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 108. Middle East Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 109. Middle East Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 110. Africa Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 111. Africa Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 112. Africa Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 113. Africa Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 114. Africa Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 115. Africa Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 116. Africa Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 117. Africa Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 118. Global Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. ASEAN Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 120. ASEAN Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 121. ASEAN Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 122. ASEAN Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 123. ASEAN Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 124. ASEAN Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 125. ASEAN Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 126. ASEAN Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 127. GCC Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 128. GCC Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 129. GCC Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 130. GCC Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 131. GCC Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 132. GCC Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 133. GCC Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 134. GCC Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 135. European Union Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 136. European Union Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 137. European Union Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 138. European Union Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 139. European Union Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 140. European Union Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 141. European Union Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 142. European Union Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 143. BRICS Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 144. BRICS Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 145. BRICS Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 146. BRICS Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 147. BRICS Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 148. BRICS Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 149. BRICS Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 150. BRICS Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 151. G7 Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 152. G7 Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 153. G7 Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 154. G7 Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 155. G7 Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 156. G7 Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 157. G7 Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 158. G7 Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 159. NATO Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 160. NATO Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 161. NATO Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 162. NATO Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 163. NATO Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 164. NATO Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 165. NATO Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 166. NATO Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 167. Global Antifungal Drugs for Skin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 168. United States Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 169. United States Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 170. United States Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 171. United States Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 172. United States Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 173. United States Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 174. United States Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 175. United States Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 176. Canada Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 177. Canada Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 178. Canada Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 179. Canada Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 180. Canada Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 181. Canada Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 182. Canada Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 183. Canada Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 184. Mexico Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 185. Mexico Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 186. Mexico Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 187. Mexico Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 188. Mexico Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 189. Mexico Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 190. Mexico Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 191. Mexico Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 192. Brazil Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 193. Brazil Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 194. Brazil Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 195. Brazil Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 196. Brazil Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 197. Brazil Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 198. Brazil Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 199. Brazil Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 200. United Kingdom Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 201. United Kingdom Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 202. United Kingdom Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 203. United Kingdom Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 204. United Kingdom Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 205. United Kingdom Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 206. United Kingdom Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 207. United Kingdom Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 208. Germany Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 209. Germany Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 210. Germany Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 211. Germany Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 212. Germany Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 213. Germany Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 214. Germany Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 215. Germany Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 216. France Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 217. France Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 218. France Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 219. France Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 220. France Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 221. France Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 222. France Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 223. France Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 224. Russia Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 225. Russia Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 226. Russia Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 227. Russia Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 228. Russia Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 229. Russia Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 230. Russia Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 231. Russia Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 232. Italy Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 233. Italy Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 234. Italy Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 235. Italy Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 236. Italy Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 237. Italy Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 238. Italy Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 239. Italy Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 240. Spain Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 241. Spain Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 242. Spain Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 243. Spain Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 244. Spain Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 245. Spain Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 246. Spain Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 247. Spain Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 248. China Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 249. China Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 250. China Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 251. China Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 252. China Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 253. China Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 254. China Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 255. China Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 256. India Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 257. India Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 258. India Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 259. India Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 260. India Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 261. India Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 262. India Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 263. India Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 264. Japan Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 265. Japan Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 266. Japan Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 267. Japan Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 268. Japan Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 269. Japan Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 270. Japan Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 271. Japan Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 272. Australia Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 273. Australia Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 274. Australia Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 275. Australia Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 276. Australia Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 277. Australia Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 278. Australia Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 279. Australia Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 280. South Korea Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
  • TABLE 281. South Korea Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
  • TABLE 282. South Korea Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
  • TABLE 283. South Korea Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
  • TABLE 284. South Korea Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 285. South Korea Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 286. South Korea Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 287. South Korea Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 288. Global Antifungal Drugs for Skin Market Share, by Key Player, 2025
  • TABLE 289. Global Antifungal Drugs for Skin Market, Key Experts